Acotec Scientific Holdings Limited (6669.HK)
HKD 7.08
(0.85%)
HKD 7.08
(0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -12.88 Million | -68.75 Million | -10.47 Million | -8.76 Million | 19.85 Million |
| Net Income | 14.45 Million | 70.31 Million | -67.24 Million | -31.44 Million | 26.7 Million |
| Depreciation & Amortization | 46.25 Million | 19.44 Million | 9.7 Million | 5.36 Million | 3.89 Million |
| Deferred income taxes | - | - | -7.52 Million | -2.87 Million | - |
| Stock-based compensation | 5.26 Million | 15.25 Million | 33.35 Million | 51.95 Million | - |
| Change in working capital | -68.12 Million | -147.98 Million | -11.32 Million | -32.69 Million | -10.95 Million |
| Other non-cash items | -8.54 Million | -25.77 Million | 32.55 Million | 934 Thousand | 202 Thousand |
| Investing Cash Flow | -319.21 Million | -49.17 Million | -20.47 Million | -17.73 Million | -2.31 Million |
| Investments in PPE | -79.65 Million | -46.69 Million | -21.23 Million | -18.62 Million | -2.69 Million |
| Acquisitions | -5.51 Million | -15.55 Million | 2.24 Million | 672 Thousand | 396 Thousand |
| Investment purchases | -247.06 Million | -7.45 Million | -39 Million | -97 Million | -51 Million |
| Sales/Maturities of investments | - | - | 39.05 Million | 97.58 Million | 51.34 Million |
| Other Investing Activities | -4.72 Million | 20.52 Million | -1.54 Million | -368 Thousand | -364 Thousand |
| Financing Cash Flow | -23.2 Million | -32.86 Million | 1.02 Billion | 142.52 Million | -3.19 Million |
| Debt repayment | -10 Million | -6 Million | -166.69 Million | -4.39 Million | -1.83 Million |
| Dividends payments | - | - | -323.08 Million | - | - |
| Common Stock Repurchased | - | -16.55 Million | - | - | - |
| Common Stock Issuance | - | -16.56 Million | 1.43 Billion | - | - |
| Other Financing Activities | 42 Thousand | 22.81 Million | 82.66 Million | 146.91 Million | -1.35 Million |
| Accounts receivables | -11.55 Million | -87.8 Million | -13.88 Million | -26.21 Million | 3.53 Million |
| Accounts payables | - | 87.8 Million | 13.88 Million | 26.21 Million | -3.53 Million |
| Inventory | -34.79 Million | -72.37 Million | -12.33 Million | 2.94 Million | 1.55 Million |
| Other working capital | -15.67 Million | -75.61 Million | 1 Million | -35.64 Million | -12.5 Million |
| Cash at beginning of period | 986.45 Million | 1.13 Billion | 147.09 Million | 31.52 Million | 17.17 Million |
| Cash at end of period | 637.62 Million | 986.45 Million | 1.13 Billion | 147.09 Million | 31.52 Million |
| Capital Expenditure | -79.65 Million | -46.69 Million | -21.23 Million | -18.62 Million | -2.69 Million |
| Effect of forex changes on cash | 6.47 Million | 62 Thousand | -3.06 Million | -447 Thousand | - |
| Net cash flow / Change in cash | -348.82 Million | -150.72 Million | 990.08 Million | 115.57 Million | 14.34 Million |
| Free Cash Flow | -92.54 Million | -115.45 Million | -31.71 Million | -27.39 Million | 17.15 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.97 Million | 19.97 Million | -3.94 Million | 14.45 Million | -3.94 Million | 11.18 Million |
| Depreciation & Amortization | 12.41 Million | 12.41 Million | 12.64 Million | 46.25 Million | 12.34 Million | 10.48 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 5.26 Million | - | 2.63 Million |
| Change in working capital | - | - | -31.01 Million | -68.12 Million | -31.01 Million | - |
| Other non-cash items | -7.32 Million | -7.32 Million | 10.9 Million | -8.54 Million | 11.21 Million | -19.34 Million |
| Investing Cash Flow | -7.83 Million | -7.83 Million | -142.33 Million | -319.21 Million | -142.33 Million | -17.27 Million |
| Investments in PPE | -14.18 Million | -14.18 Million | -26.93 Million | -79.65 Million | -26.93 Million | -12.86 Million |
| Acquisitions | - | - | - | -5.51 Million | - | - |
| Investment purchases | - | - | - | -247.06 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6.35 Million | 6.35 Million | -115.4 Million | -4.72 Million | -115.4 Million | -4.4 Million |
| Financing Cash Flow | 13.27 Million | 13.27 Million | -4.51 Million | -23.2 Million | -4.51 Million | -7.09 Million |
| Debt repayment | - | - | - | -10 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 13.27 Million | 13.27 Million | -4.51 Million | 42 Thousand | -4.51 Million | -7.09 Million |
| Accounts receivables | - | - | -5.77 Million | -11.55 Million | -5.77 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -17.39 Million | -34.79 Million | -17.39 Million | - |
| Other working capital | - | - | -7.83 Million | -15.67 Million | -7.83 Million | - |
| Cash at beginning of period | - | - | - | 986.45 Million | - | - |
| Cash at end of period | 30.7 Million | 30.7 Million | -155.07 Million | 637.62 Million | -155.07 Million | -19.33 Million |
| Capital Expenditure | -14.18 Million | -14.18 Million | -26.93 Million | -79.65 Million | -26.93 Million | -12.86 Million |
| Effect of forex changes on cash | 186 Thousand | 186 Thousand | 3.17 Million | 6.47 Million | 3.17 Million | 68 Thousand |
| Net cash flow / Change in cash | 30.7 Million | 30.7 Million | -155.07 Million | -348.82 Million | -155.07 Million | -19.33 Million |
| Free Cash Flow | 10.88 Million | 10.88 Million | -38.33 Million | -92.54 Million | -38.33 Million | -7.9 Million |
MANTEX
2247
2534
TNY
CRE
600180